Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Shortening the duration of treatment with HCV direct-acting antivirals (DAAs) leads to substantial cost reductions. According to the label, sofosbuvir and ledipasvir can be prescribed for 8 weeks (SL8) in noncirrhotic women or men with HCV genotype 1 and low viral loads. However, real-world data about the efficacy and safety of SL8 are largely missing.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin. Infect. Dis.

Title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Publisher: Oxford University Press (OUP)

ISSN (Electronic): 1537-6591

ISSN (Print): 1058-4838

Publication date (Electronic): November 15 2016

Volume: 63

Issue: 10

Affiliations

[1 ] Center for Infectiology Berlin.

[2 ] Center for Interdisciplinary Medicine Muenster.

[3 ] Faculty of Medicine, Department of Surgery and Cancer, Imperial College London, United Kingdom.

[4 ] Gastroenterology Practice, Herne.

[5 ] Infektiologikum, Frankfurt.

[6 ] Infectiology Center in Hamburg.

[7 ] Center for HIV and Hepatogastroenterology, Duesseldorf.

[8 ] Ambulanzzentrum Virushepatologie, University Medical Center Hamburg-Eppendorf and DZIF Partner Site, Hamburg.

[9 ] Medical Department I, University Hospital, Bonn.

[10 ] Klinische Arbeitsgemeinschaft AIDS, Bonn.

[11 ] Gastroenterology Practice, Leverkusen, Germany.

Article

Publisher Item ID: ciw567

DOI: 10.1093/cid/ciw567

PubMed ID: 27535952

SO-VID: a2aca82b-d274-470c-8604-2ad6d872035f

History

Keywords: sofosbuvir,8 weeks,HIV coinfection,ledipasvir,short course treatment

Data availability:

Keywords: sofosbuvir, 8 weeks, HIV coinfection, ledipasvir, short course treatment

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).

Read this article at

Abstract

Related collections

Point-Of-Care Testing for Hepatitis

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 6

Cited by 23